Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines

Overview of attention for article published in Cochrane database of systematic reviews, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 10 X users

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 77 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Systematic Review | Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.

SPECIALTIES, 21 Oct 2022

Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines – Cochrane…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.